Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Dabakuyo · SciRah

Researcher profile · Semantic Scholar

S. Dabakuyo

Share profile

S. Dabakuyo — researcher profile on SciRah

h-index: 5
Works: 26
Citations: 380

Most-cited papers

In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival
S. Ladoire, G. Mignot, S. Dabakuyo, L. Arnould +10 more
2011Journal of Pathology240 citations
Semantic Scholar
Evaluation of quality of life after breast reconstruction using an autologous latissimus dorsi myocutaneous flap.
E. de Gournay, F. Bonnetain, H. Tixier, C. Loustalot +2 more
2010European Journal of Surgical Oncology32 citations
Semantic Scholar
Real-life prognosis of 5041 bone-only metastatic breast cancer patients in the multicenter national observational ESME program
M. Bertho, J. Fraisse, A. Patsouris, P. Cottu +20 more
2021Therapeutic Advances in Medical Oncology28 citations Open access
Semantic Scholar
PRACTICE PATTERNS AND 90-DAY TREATMENT-RELATED MORBIDITY IN EARLY-STAGE CERVICAL CANCER
G. Bogani, V. Di Donato, G. Scambia, P. Panici +24 more
202225 citations
Semantic Scholar
Prognostic value of health‐related quality of life for death risk stratification in patients with unresectable glioblastoma
B. Paquette, Dewi Vernerey, B. Chauffert, S. Dabakuyo +19 more
2016Cancer Medicine21 citations Open access
Semantic Scholar
Prevalence, clinicopathologic features and long-term overall survival of early breast cancer patients eligible for adjuvant abemaciclib and/or ribociclib
S. Ladoire, A. M. Kamga, L. Galland, M. Réda +10 more
2025npj Breast Cancer5 citations Open access
Semantic Scholar
Atezolizumab and paclitaxel as first line therapy in advanced triple-negative breast cancer patients included in the French early access program
Alexandre de Moura, P. Vuagnat, B. Renouf, J. Pierga +15 more
2023Scientific Reports5 citations Open access
Semantic Scholar
Neoadjuvant therapy for breast cancer has no benefits on overall survival or on the mastectomy rate in routine clinical practice. A population-based study with a median follow-up of 11 years using propensity score matching.
I. Le Ray, S. Dabakuyo, G. Créhange, Marc Bardou +8 more
2012European Journal of Cancer5 citations
Semantic Scholar
Real-world prevalence, treatment and survival of “high risk” early breast cancer, with mandatory testing of gBRCA1/2 mutation according to the OlympiA trial inclusion criteria: Data from a population-based registry
S. Ladoire, Ariane Mamguem Kamga, L. Galland, I. Desmoulins +12 more
2024Breast4 citations Open access
Semantic Scholar
Impact of therapeutic strategy on disease‐free and overall survival of early‐stage cervical cancer: Surgery alone versus preoperative radiation
K. Mahiou, Laura Vincent, K. Peignaux-Casasnovas, H. Costaz +6 more
2023Cancer Reports4 citations Open access
Semantic Scholar
Fostering patients' participation in oncology research by developing psychological empowerment and a sense of community.
C. Bauquier, M. Pannard, Amandine Andrin, Julien Biaudet +6 more
2024Journal of epidemiology and population health3 citations Open access
Semantic Scholar
Impact of breast surgical procedure on survival in BRCA mutated patients with invasive breast cancer: mastectomy versus conservative treatment.
K. Mahiou, C. Jankowski, Laura Vincent, H. Costaz +4 more
2024Journal of Gynecology Obstetrics and Human Reproduction3 citations Open access
Semantic Scholar
HER2-positive invasive lobular carcinoma: a rare breast cancer which may not necessarily require anti-HER2 therapy. A population-based study
Samia Kada Mohammed, O. Billa, S. Ladoire, C. Jankowski +6 more
2023Breast Cancer3 citations
Semantic Scholar
Impact of complete surgical staging on survival of patients with early-stage (FIGO I or II) ovarian cancer: Data from the Cote d'Or Registry of Gynecological Cancers from 1998 to 2015.
Eloise Michel, Ariane Mamguem Kamga, A. Amet, M. Padeano +7 more
2023Bulletin du Cancer2 citations Open access
Semantic Scholar
[Para-aortic lymph node staging in grade IB2 and above cervical cancers: comparison of 18FDG PET-CT with para-aortic lymphadenectomy, using data from the Côte d'Or gynaecological cancer registry from 2003 to 2016].
Anne Carre, J. Sellier, A. M. Kamga, S. Dabakuyo +2 more
2021Gynécologie Obstétrique Fertilité & Sénologie1 citations
Semantic Scholar
Assessing quality of life in individuals with hereditary cancer risk: Results from phases 1-3a of the EORTC QLQ-HCR30 questionnaire.
V. Engele, V. Vassiliou, S. Wheelwright, M. Sztankay +17 more
2026European Journal of Cancer0 citations Open access
Semantic Scholar
Abstract PO5-11-04: Sexuality and fertility profiles, Health-Related Quality of Life and other living conditions of young breast cancer survivors in France: a national cross-sectional study by the French Network of Cancer Registries (FRANCIM)
E. Assogba, Caroline Mollévi, A. Woronoff, Agnès Dumas +5 more
2024Cancer Research0 citations
Semantic Scholar
Abstract PO5-11-05: Fertility, sexuality and other unmet needs of young breast cancer survivor during and at the end of treatment in France: a national qualitative study by the French Network of Cancer Registries (FRANCIM)
E. Assogba, Agnès Dumas, C. Morgny, Myriam Borel +6 more
2024Cancer Research0 citations
Semantic Scholar
Abstract P1-03-04: Visceral fat area as a predictive factor in metastatic HER2 negative breast cancer patients treated by first line chemotherapy with weekly paclitaxel and bevacizumab
S. Guiu, B. Guiu, M. Chevrier, O. Billa +15 more
2023Cancer Research0 citations
Semantic Scholar
Abstract P4-07-54: Health related quality of life of patients treated with bevacizumab and paclitaxel as first-line treatment for HER2 negative metastatic breast cancer: impact of clinical factors
O. Billa, S. Dabakuyo, M. Chevrier, F. Bonnetain +17 more
2023Cancer Research0 citations
Semantic Scholar
Abstract P1-09-11: Impact of breast surgical procedure on survival in BRCA mutated patients with invasive breast cancer: mastectomy versus conservative treatment
C. Jankowski, K. Mahiou, Vincent Laura, H. Costaz +5 more
2023Cancer Research0 citations
Semantic Scholar
Abstract P4-07-24: Circulating tumor cells enumeration and Health Related Quality of Life of patients treated with first-line chemotherapy for HER2 negative metastatic breast cancer
J. Pierga, O. Billa, S. Dabakuyo, J. Lemonnier +14 more
2023Cancer Research0 citations
Semantic Scholar
2022-RA-177-ESGO Impact of therapeutic strategy on disease-free and overall survival of early stage cervical cancer: surgery aloneversuspre-operative radiotherapy
K. Mahiou, Laura Vincent, K. Peignaux-Casasnovas, H. Costaz +5 more
2022Cervical cancer0 citations Open access
Semantic Scholar
350 Impact on survival of surgical therapeutic strategy in the initial management of advanced ovarian cancer
A. Amet, H. Costaz, J.-D. Fumet, L. Arnould +5 more
2021Ovarian cancer0 citations Open access
Semantic Scholar
Baseline quality of life (QoL) and chemotherapy related toxicities (CRT) in localized breast cancer (BC) patients (pts): The French multicentric prospective CANTO cohort study
I. Licaj, S. Dabakuyo, S. Dauchy, I. Luis +16 more
2019Annals of Oncology0 citations Open access
Semantic Scholar
Abstract P3-08-07: HER2 positive breast carcinomas: trend in evolution between 1998 and 2008 and relationship with clinico-pathological characteristics in a population based study.
F. Beltjens, A. Bertaut, S. Pigeonnat, N. Pouget +8 more
20120 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Coutant×7
Invite
C. Coutant — researcher profile on SciRah
H. Costaz×7
Invite
H. Costaz — researcher profile on SciRah
I. Desmoulins×7
Invite
I. Desmoulins — researcher profile on SciRah
L. Arnould×6
Invite
L. Arnould — researcher profile on SciRah

×6

Invite

F. Bonnetain — researcher profile on SciRah

Invite

M. Padeano — researcher profile on SciRah

Invite

C. Lévy — researcher profile on SciRah

Invite

K. Mahiou — researcher profile on SciRah

Invite

A. Amet — researcher profile on SciRah

C. Jankowski×5

Invite

C. Jankowski — researcher profile on SciRah

Invite

C. Coutant — researcher profile on SciRah

A. Gonçalves×4

Invite

A. Gonçalves — researcher profile on SciRah